Xiaofeng Tie
机构：Chinese Academy of Medical Sciences & Peking Union Medical College, Nanjing Medical University
发表论文 8 篇 · 总被引 88 次 · h-index 4
代表论文
- CRISPR/Cas9 screen reveals that targeting TRIM34 enhances ferroptosis sensitivity and augments immunotherapy efficacy in hepatocellular carcinoma (2024 · Cancer Letters · 被引 36)
- eIF3f promotes tumour malignancy by remodelling fatty acid biosynthesis in hepatocellular carcinoma (2025 · Journal of Hepatology · 被引 30)
- Lactate metabolism and lactylation in cancer: from pathogenesis to therapeutic advances (2026 · Signal Transduction and Targeted Therapy · 被引 5)
- Ciprofol exerts anti-tumour effects in hepatocellular carcinoma through the Raf-MEK-ERK signalling pathway (2025 · Translational Gastroenterology and Hepatology · 被引 2)
- Landscape screening identifies the lactate-modifying enzyme AARS2 as a master regulator and therapeutic target in hepatocellular carcinoma (2026 · Gut · 被引 1)
- JOSD1 drives hepatocellular carcinoma malignancy by modulating the ubiquitination-lactylation switch on PGAM1 (2026 · Gut · 被引 1)